Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimen.

If the concept of the first digital divide was particularly linked to access to Internet, and the second digital divide to the operational capacity of the ICT‟s, the

OFF-LINE SIGNATURE IMAGE MEASURES We propose two automatic measures: the first measures the area of a signature where slants with different directions in- tersect, while the

BACKGROUND: The efficacy and safety of capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer (mCRC) considered unsuitable for receiving

OPUS, Oxaliplatin and Cetuximab in First-Line Treatment of Metastatic Colorectal Cancer; PEAK, Panitumumab Efficacy in Combination With mFOLFOX6 Against Bevacizumab Plus mFOLOFOX6

is in line with the assumption that some players are disapproval–averse, because the coopera- tion rate in the control treatment is strictly positive and in the expectations

Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with

(A –C) Numerical solution of the model equations showing the time evolution of healthy (blue line) and unhealthy (red line) cells after treatment with different combinations

Arthro- scopic techniques include shaving of the dorsal side of the proximal tendon, removal of the hypertrophic synovitis around the inferior patellar pole with a bipolar cautery